ADVFN US – Market Content Editor

Atmus Filtration Technologies Inc. (NYSE:ATMU), a global leader in filtration and media solutions, reported second-quarter results that notably exceeded analyst projections, pushing shares up 2% after the announcement. The company posted adjusted earnings per share of $0.75, comfortably outperforming the $0.52 estimate by 23 cents. Revenue reached $454 million, well above the consensus forecast of…

Essent Group Ltd. (NYSE:ESNT) reported second-quarter earnings on Friday that beat analyst forecasts, driven by robust credit results and higher investment income. The mortgage insurer posted earnings of $1.93 per diluted share, well above the estimated $1.72. Shares in the company inched up 0.07% in after-hours trading following the announcement. For the quarter ending June…

Embecta Corp. (NASDAQ:EMBC) saw its shares climb 2.32% in after-hours trading Friday, following the release of strong third-quarter results that exceeded analyst expectations thanks to effective commercial execution and favorable customer order timing. For the fiscal third quarter ending June 30, 2025, the global diabetes care company posted adjusted earnings of $1.12 per share, well…

Tempus AI (NASDAQ:TEM) surged 9% in premarket trading on Friday after the genetic testing company posted a smaller-than-expected loss per share for the second quarter and raised its revenue guidance. The firm reported a loss of $0.22 per share, beating analysts’ forecasted loss of $0.25. Revenue reached $314.6 million, surpassing the consensus estimate of $297.8…

Gray Media Inc. (NYSE:GTN) saw its shares rise 5.07% in after-hours trading on Friday following the release of its second-quarter financial results, which showed revenue above analyst forecasts despite a larger-than-expected loss. The multimedia broadcaster reported Q2 revenue of $772 million, beating the consensus estimate of $766.31 million, though this marked a 7% decline from…

Shares of Novo Nordisk (NYSE:NVO), traded in Copenhagen, rose over 5% on Friday, extending gains from the previous session. The boost came after rival Eli Lilly (NYSE:LLY) released trial results showing its weight-loss pill was less effective than Novo’s blockbuster drug, Wegovy. On Thursday, Lilly announced that its late-stage trial of the experimental GLP-1 pill,…

Shares of Block Inc (NYSE:XYZ) jumped 8% in premarket trading on Friday following the company’s second-quarter report that showcased impressive gross profit growth, even as adjusted earnings per share fell short of forecasts. Investor confidence was buoyed by solid performance in the Cash App and Square divisions, along with an upgraded full-year outlook. Block recorded…

VTEX (NYSE:VTEX) announced second-quarter results that fell short of subscription revenue expectations, leading the company to lower its growth projections for the rest of 2025 amid difficulties in Brazil and Argentina. The e-commerce platform provider’s subscription revenue increased 11.2% on a constant currency basis, missing the previously guided range of 12.5% to 15.5% and coming…

FibroGen Inc. (NASDAQ:FGEN) saw its stock jump nearly 10% after receiving encouraging feedback from the U.S. Food and Drug Administration (FDA) regarding the development of roxadustat for treating anemia in patients with low-risk myelodysplastic syndromes (LR-MDS) who rely heavily on red blood cell transfusions. The FDA’s positive response followed a Type C meeting where FibroGen…

Gilead Sciences (NASDAQ:GILD) saw its stock climb in after-hours trading on Friday, following an upbeat quarterly performance and a raised full-year outlook, driven by resilient demand for its HIV therapies. For the second quarter, the company reported adjusted earnings of $2.01 per share on revenue of $7.1 billion—both figures topping Wall Street expectations, which stood…